Rhineton (4 Mg Tablet) 4mg Tablet
PDF Leaflet Revision Date: 04 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of allergic rhinitis and skin manifestations.
Dosage (summary)
Adults: 4 mg every 4-6 hours, max 24 mg/day.
Onset of Action / Duration
Onset: 30 mins, Duration: 4-6 hours
Special Populations
- Elderly
- Children under 6 years
Pregnancy & Breastfeeding
Safety in pregnancy not established; may inhibit lactation.
Key Drug Interactions
- Alcohol
- MAO inhibitors
- Tricyclic antidepressants
Contraindications
- Hypersensitivity to chlorpheniramine
- MAO inhibitor therapy
Common side effects
- Drowsiness
- Dizziness
- Dry mouth
- Nausea
Counselling Points
- Avoid alcohol and sedatives
- Consult doctor if breathing problems exist
- Do not exceed recommended dosage
Serious warnings
- May impair ability to drive
- Caution in elderly
- Risk of paradoxical excitation in children
Important Disclaimer
The Rhineton (4 Mg Tablet) 4mg Tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
